Dna X (SONM) Cash from Financing Activities (2018 - 2025)

Dna X has reported Cash from Financing Activities for 8 years, with the latest figure at $1.2 million in Q4 2025.

• For the quarter ending Q4 2025, Cash from Financing Activities rose 46.25% year-over-year to $1.2 million; the trailing twelve-month figure through Dec 2025 stood at $19.5 million (up 319.41% YoY), and the FY2025 full-year result was $19.5 million, up 319.41% from the prior year.
• Cash from Financing Activities for Q4 2025 stood at $1.2 million, down from $7.2 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $18.6 million in Q4 2021, with the low at -$37000.0 in Q1 2023.
• Historically, Cash from Financing Activities has averaged $3.3 million across 5 years, with a median of $591000.0 in 2023.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities soared 676200.0% — and 2023, when it plunged 511.11%.
• Dna X's Cash from Financing Activities stood at $18.6 million in 2021, then sank by 100.19% to -$36000.0 in 2022, then dropped by 2.78% to -$37000.0 in 2023, then jumped by 2262.16% to $800000.0 in 2024, then soared by 46.25% to $1.2 million in 2025.
• The last three Cash from Financing Activities figures came in at $1.2 million (Q4 2025), $7.2 million (Q3 2025), and $4.8 million (Q2 2025), per Business Quant data.